FDA NDC Directory · JSON-LD · Markdown

Bepotastine Besilate

NDC 70069-711 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerSomerset Therapeutics, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217770
Dosage form / routeSOLUTION · OPHTHALMIC
Active ingredientsBEPOTASTINE BESILATE (15 mg/mL)
Marketing started20241010
Package count1

External sources

Source: openFDA. Public-domain (CC0).